Condition: Agitation Associated With Alzheimer's Disease Dementia · Sponsor: Ono Pharmaceutical Co., Ltd.
To evaluate the efficacy and safety of ONO-2020 in patients with agitation associated with Alzheimer's Disease dementia in Japan.
This description comes directly from the study's public registry record.
North America Clinical Trial Support Desk · +18665877745(Toll-Free) · clinical_trial@ono-pharma.com
International Clinical Trial Support Desk · +17162141777(Standard) · clinical_trial@ono-pharma.com
Always discuss trial participation with your own doctor first.
| Hotei Hospital | Aichi, Japan | Recruiting |
| Akita Prefectural Center For Rehabilitation and Psychiatric Medicine | Akita, Japan | Recruiting |
| Medical Corporation Keishinkai Kyowa Hospital | Akita, Japan | Recruiting |
| Aiseikai General Incorporated Foundation, Hirosaki Aiseikai Hospital | Aomori, Japan | Recruiting |
| Seinan Hospital | Aomori, Japan | Recruiting |
| Fukui Hospital | Fukui, Japan | Recruiting |
| Matsubara Hospital | Fukui, Japan | Recruiting |
| Aburayama Hospital | Fukuoka, Japan | Recruiting |
| Kuramitsu Hospital | Fukuoka, Japan | Recruiting |
| Kishikai Kishi Hospital | Gunma, Japan | Recruiting |
| Hayakawa Clinic | Hiroshima, Japan | Recruiting |
| Koseikai Cocoro Hospital Kusatsu | Hiroshima, Japan | Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06803823